Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Excessive Daytime Sleepiness in Narcolepsy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01006122
What this trial is testing

A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

Who this might be right for
Excessive Daytime SleepinessNarcolepsy
Pfizer 95
Not applicableNo Longer AvailableNCT03433131
What this trial is testing

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Who this might be right for
Narcolepsy Without CataplexyNarcolepsy With Cataplexy
Harmony Biosciences Management, Inc.
Large-scale testing (Phase 3)Study completedNCT00228553
What this trial is testing

Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness

Who this might be right for
Excessive Daytime SleepinessNarcolepsyObstructive Sleep Apnea/Hypopnea Syndrome+1 more
Cephalon 743
Large-scale testing (Phase 3)Looking for participantsNCT06767683
What this trial is testing

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Alkermes, Inc. 256